Anhydrous sodium thiosulfate, also known as Pedmarqsi and made by Norgine, is recommended in final draft guidance for preventing hearing loss caused by cisplatin chemotherapy in children from the ages ...

We’ve issued final draft guidance recommending a new once-a-day tablet that is set to benefit around 1,100 people with a type ...

NICE inherited the 7 highly specialised technologies (HST) routing criteria from AGNSS (Advisory Group for National Specialised Services) in 2013. Following that, the NICE Highly Specialised ...

NICE is proposing changes to its routing criteria for Highly Specialised Technologies (HST) to ensure more consistent, ...

The National Institute for Health and Care Excellence (NICE) is producing guidance on Novel home-testing devices for diagnosing obstructive sleep apnoea/hypopnoea syndrome. The diagnostics advisory ...

NICE intends to develop tools, in association with relevant stakeholders, to help organisations put this guidance into practice. In addition, NICE will support this guidance through a range of ...

This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...

The following considerations around implementing the evidence generation process have been identified through working with system partners: ...